Arthritis & Rheumatism. 2006;54(12):3859-3867. Degenerative disc disease is one of today's most common and costly medical conditions. Marked by the gradual erosion of cartilage between the ...

Creative Medical Technology (CELZ) announced initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT, the ...

Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

Technology Holdings, Inc. (NASDAQ:CELZ), a clinical-stage biotechnology firm, has announced a strategic collaboration with Greenstone Biosciences Inc. to utilize Artificial Intelligence (AI) in ...

Northwestern Medicine is a global leader in clinical trial research, including spine CLARITY is a randomized study designed ...

FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...

Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis. The rising prevalence of chronic pain drives market growth by ...

Chief Strategy Officer Ryan Bond stated, "This milestone ensures we reach the study's conclusion, potentially unlocking broad ...

Many aspects of the physiology of the intervertebral disc (IVD) show clear diurnal rhythms ... These results support the concept that disruptions to circadian rhythms may be a risk factor for ...

22, 2024 — A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically ...

Dr. Sigurd Berven to Highlight NOCISCAN Capabilities, Combining MR Spectroscopy and Augmented Intelligence (AI) NOCISCAN as New Gold Standard in Identifying a Source of Discogenic Pain BROOMFIELD, ...